Evidence map›Paper›PMID 35806867›Full record

ArticleJournal of clinical medicine2022

Ferritin Trajectories over Repeated Whole Blood Donations: Results from the FIND+ Study.

Sara Moazzen, Maike G Sweegers, Mart Janssen, Boris M Hogema, Trynke Hoekstra, Katja Van den Hurk

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Sara MoazzenMolecular Epidemiology Research Group, Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft, 13125 Berlin, Germany.
Maike G SweegersDonor Studies, Department of Donor Medicine Research, Sanquin Research, 1066CX Amsterdam, The Netherlands.
Mart JanssenTransfusion Technology Assessment, Department of Donor Medicine Research, Sanquin Research, 1066CX Amsterdam, The Netherlands.ORCID 0000-0002-1682-7817
Boris M HogemaBlood-Borne Infections, Department of Donor Medicine Research, Sanquin Research, 1066CX Amsterdam, The Netherlands.
Trynke HoekstraDepartment of Health Sciences or Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, 1007MB Amsterdam, The Netherlands.ORCID 0000-0002-0535-0056
Katja Van den HurkDonor Studies, Department of Donor Medicine Research, Sanquin Research, 1066CX Amsterdam, The Netherlands.ORCID 0000-0003-3241-6003
Sanquin · NLMax Delbrück Center · DEVrije Universiteit Amsterdam · NL

Funding

European Blood Alliance 2019
6 · The paper itself

Abstract

backgroundDepending on post-donation erythropoiesis, available iron stores, and iron absorption rates, optimal donation intervals may differ between donors. This project aims to define subpopulations of donors with different ferritin trajectories over repeated donations.

methodsFerritin levels of 300 new whole blood donors were measured from stored (lookback) samples from each donation over two years in an observational cohort study. Latent classes of ferritin level trajectories were investigated separately using growth mixture models for male and female donors. General linear mixed models assessed associations of ferritin levels with subsequent iron deficiency and/or low hemoglobin.

resultsTwo groups of donors were identified using group-based trajectory modeling in both genders. Ferritin levels showed rather linear reductions among 42.9% of male donors and 87.7% of female donors. For the remaining groups of donors, steeper declines in ferritin levels were observed. Ferritin levels at baseline and the end of follow-up varied greatly between groups.

conclusionsRepeated ferritin measurements show depleting iron stores in all-new whole blood donors, the level at which mainly depends on baseline ferritin levels. Tailored, less intensive donation strategies might help to prevent low iron in donors, and could be supported with ferritin monitoring and/or iron supplementation.

Indexed as

bloodblood donorsferritins

Identifiers

PMID35806867
PMCPMC9267857
OpenAlexW4283256886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.